Second VPH Industry Day

8-9 September 2010, Barcelona, Spain.
The second VPH Industry Day, organised by the European Network of Excellence for the Virtual Physiological Human (VPH), aims to increase the awareness amongst European Industry of the vision, the concepts, and the concrete technological achievements of VPH-related research.

This year the event is organised around three themes:

  • Research to Business (R2B): VPH research projects are presented to industry experts both in terms of vision and of exploitable results.
  • Business to Business (B2B): Companies present to other companies concepts, products and services that can be used to develop VPH-related products.
  • Regulatory to Business (G2B): Regulators discuss standardisation and regulatory affairs in Europe and the USA relevant for VPH-based technology.

Who should attend?
The event is an excellent opportunity for technical and managerial staff in small and large biomedical companies to learn and prepare for developments in personalised and predictive medicine in the short and medium terms.

Registration
VPH Industry Day 2010 will be held 8-9 September 2010 in Barcelona (Spain), at the Universitat Pompeu Fabra. The event is open and free to all. However, since the number of seats available is limited we kindly request you register online to the event in advance at the following link:
http://www.cdti.es/index.asp?IDIOMA=2&MP=15&MS=63&MN=3&idr=1264

Once you are registered you will receive events updates via email, including the final program, suggestions for accommodation, etc.

For further information, please visit:
http://www.vph-noe.eu

Related news articles:

About the VPH Network of Excellence
The VPH Network of Excellence (VPH NoE) is designed to foster, harmonise and integrate pan-European research in the field of i) patient-specific computer models for personalised and predictive healthcare and ii) ICT-based tools for modelling and simulation of human physiology and disease-related processes.

The main objectives of the VPH Network of Excellence are to support the:

  • Coordination of research portfolios of VPH NoE partners through initiation of Exemplar integrative research projects that encourage inter-institution and interdisciplinary VPH research.
  • Integration of research infrastructures of VPH NoE partners through development of the VPH ToolKit: a shared and mutually accessible source of research equipment, managerial and research infrastructures, facilities and services.
  • Development of a portfolio of interdisciplinary training activities including a formal consultation on, and assessment of, VPH careers.
  • Establishment of a core set of VPH-related dissemination and networking activities which will engage everyone from partners within the VPH NoE/other VPH projects, to national policy makers, to the public at large.
  • Creation of Industrial, Clinical and Scientific Advisory Boards that will jointly guide the direction of the VPH NoE and, through consultation, explore the practical and legal options for real and durable integration within the VPH research community.
  • Implementation of key working groups that will pursue specific issues relating to VPH, notably integrating VPH research worldwide through international physiome initiatives.

Finally, by involving clinical and industrial stakeholders, VPH NoE also plans to lay a reliable ground to support sustainable interactions and collaboration between research and healthcare communities.

Most Popular Now

Do Fitness Apps do More Harm than Good?

A study published in the British Journal of Health Psychology reveals the negative behavioral and psychological consequences of commercial fitness apps reported by users on social media. These impacts may...

AI Tool Beats Humans at Detecting Parasi…

Scientists at ARUP Laboratories have developed an artificial intelligence (AI) tool that detects intestinal parasites in stool samples more quickly and accurately than traditional methods, potentially transforming how labs diagnose...

Making Cancer Vaccines More Personal

In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that...

AI can Better Predict Future Risk for He…

A landmark study led by University' experts has shown that artificial intelligence can better predict how doctors should treat patients following a heart attack. The study, conducted by an international...

A New AI Model Improves the Prediction o…

Breast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the...

AI System Finds Crucial Clues for Diagno…

Doctors often must make critical decisions in minutes, relying on incomplete information. While electronic health records contain vast amounts of patient data, much of it remains difficult to interpret quickly...